• image1

INNPACTO Program

Project IOTRA: “Development of a new combination of AINES”. The Ministry of Economy and Competitiveness through INNPACTO Subprogram of the National Public-Private Cooperation within the joint line and internationalization Instrumentation System, part of the National Plan for Scientific Research, Development and Technological Innovation 2008-2011, supports Farmalider, S.A projects Through grant aid including a partially deposit refundable under funding FEDER.

ministerio-de-economia-y-competitividad


CDTI: Projects funded by the Center for Industrial Technological Development

DOLOMENS15 is an individual R & D project that aims to develop a new medicine for the menstrual cramps treatment based on an ibuprofen and paracetamol combination, with 951.894 euros global budget and a work plan which covers the period between the October 16th, 2016 until June 15th, 2018.

The main objectives of the project are the following: i) drug bioavailability study with its active comparators through a 2×2 phase I cross-over trial. ii) Analgesic efficacy and safety evaluation of the paracetamol and ibuprofen fixed-dose combination for oral administration, compared to its active comparators and placebo in dysmenorrhea with moderate or severe pain patients.

The main objectives of the project are the following: i) drug bioavailability study with its active comparators through a 2×2 phase I cross-over trial. ii) Analgesic efficacy and safety evaluation of the paracetamol and ibuprofen fixed-dose combination for oral administration, compared to its active comparators and placebo in dysmenorrhea with moderate or severe pain patients.

This project has been co-financed by the CDTI with European Union FEDER funds, through the Smart Growth Pluriregional Operative Program, 2014-2020.

DATA SHEET

• Call: R&D individual CDTI Project
• Reference: IDI-20160004
• Project Title: “New medication development against menstrual cramps”
• Acronym: DOLOMENS15
• Leader: FARMALIDER, S.A.
• Budget: 951.894,00 €
• FEDER funds financing: 809,109.90 €
• Co-financing percentage: 72.96%
• Start date: 10/16/2016
• End date: 06/15/2018

ministerio-de-economia-y-competitividad